WHO ICTRP trial
Bioequivalence study of Clozapine tablet
ChiCTR2200063238 · Chinese Clinical Trial Registry (ChiCTR) · Not Recruiting
Key facts
| Trial ID | ChiCTR2200063238 |
|---|---|
| Public title | Bioequivalence study of Clozapine tablet |
| Scientific title | A bioequivalence study of Clozapine tablet in Chinese schizophrenia patients |
| Primary sponsor | The Second Xiangya Hospital of Central South University |
| Registry | Chinese Clinical Trial Registry (ChiCTR) |
| Recruitment status | Not Recruiting |
| Study type | Interventional study |
| Phase | 1 |
| Countries | China |
| Conditions | schizophrenia |
| Interventions | T-R:Delivery order: test preparation-reference preparation;R-T:Delivery order: reference preparation-test preparation |
| Registration date | Sep 2, 2022 |
| Target size | T-R:12;R-T:12 |
| Registry page | chictr.org.cn |
At a glance
- No Results available
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About WHO ICTRP trial registrations
The WHO ICTRP combines trial registrations from primary registries worldwide into a single searchable index. Contact and ethics-committee details are not shown here.
Source: World Health Organization (WHO), International Clinical Trials Registry Platform (ICTRP) · Source date: